About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,721 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,721 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2421-2440 of 3,721 trials

CompletedTherapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple SclerosisIntroduction/Objectives: In this observational study, we assessed the benefit following an injection of 200 international units (IU) of incobotulinum toxinA in patients with…NCT04265092 CompletedHealthy Volunteer Study Using 3 Different Formulations of FirategrastThis study will investigate how 3 types of drug formulations are absorbed by the body.NCT01416363·Randwick, New South Wales CompletedImpact of Multiple Sclerosis From the Viewpoint of the Patients and Their CaregiversPatients with chronic illness and their relatives have exhaustive and specific experience of healthcare and the health service.These unique experiences must be taken into account…NCT02388334·Rennes

Related Searches

Data from ClinicalTrials.govTerms

CompletedDevelopment and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)The primary purpose of this study is to develop, implement and conduct a preliminary evaluation of a new service for people who are severely affected by multiple sclerosis.NCT00364936·London, London

RecruitingImproving Learning and Memory in Portuguese Patients With Multiple SclerosisDeficits in memory and learning are common in Multiple Sclerosis, posing significant challenges in patients' daily lives.NCT06723444·Porto

UnknownInvestigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive PatientsThe purposes of this study is to identify types of bacteria that reside in the intestine of healthy individuals and compare them to individuals with Multiple Sclerosis (MS).NCT03092544·Latham, New York

CompletedMindfulness for Newly Diagnosed Multiple SclerosisMultiple Sclerosis (MS) is a chronic neurological disease often diagnosed in a person's 20s or 30s, at a time when most people are starting careers and families.NCT03607773·London, Ontario

CompletedRespiratory Functions, Trunk Control and Mobility Evaluation in Multiple SclerosisRespiratory functions and body control are affected in patients with multiple sclerosis (MS).NCT03826095·Ankara

RecruitingWearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot StudyThis pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for…NCT07376772·Gainesville, Florida and 1 other

CompletedBetaferon Use in Children and Adolescents With Multiple SclerosisThe objective of this study is to determine efficacy, safety and tolerability of interferon beta-1b for multiple sclerosis (MS) in children and adolescentsNCT03577977·Multiple Locations

CompletedPhysiotherapist-guided Home Exercise in Moderate to Severe MSPhysical activity is a crucial component to wellness and is associated with multiple health benefits.NCT03039400·Saskatoon, Saskatchewan

CompletedA Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple SclerosisThis is a multicenter study conducted in 3 parts. Part A is a double-blind placebo-controlled parallel-group period, and Part B and C are open-label extension periods.NCT01917019·Bunkyō City and 18 others

UnknownComparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic NeuritisUltimately improve the care of patients suffering from multiple sclerosis (1st cause of acquired non-traumatic disability in adults) and NMO spectrum diseases by using more…NCT06494228·Strasbourg, Les Hôpitaux Universitaires de Strasbourg

CompletedTranscranial Direct Current Stimulation and Walking in Multiple SclerosisWeakness on one side of the body is a hallmark of Multiple Sclerosis (MS), which has been determined to be a significant cause of progressive worsening of walking abilities.NCT03757819·Iowa City, Iowa

CompletedStudy to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy VolunteersThe primary outcome of the study is to evaluate the cumulative area under the concentration time curve (AUC) over 2 weeks, as measured by AUC from time 0 to 336 hours post dose…NCT02269930·Evansville, Indiana

CompletedUS PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT AutoinjectorIn this study researchers want to learn more about the medication usage behavior among multiple sclerosis (MS) patients treated with BETASERON using the myBETAapp.NCT04356339·Whippany, New Jersey

CompletedIntranasal Insulin for Improving Cognitive Function in Multiple SclerosisThis study will evaluate if giving insulin that is administered in the nostrils (intranasal) is safe and tolerable for people with multiple sclerosis (MS).NCT02988401·Baltimore, Maryland

CompletedTHE EFFECTS OF AEROBİC EXERCİSE ON NEUROVASCULAR UNİT AND CLİNİCAL PROGRESSİON MARKERS İN INDİVİDUALS WİTH MULTİPLE SCLEROSİSThis study is a randomised controlled trial designed to thoroughly investigate the effects of aerobic exercise on NVU biomarkers in individuals with MS. The study was conducted…NCT07325019·Ankara

Active not recruitingMRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)This is a Phase 2 multicenter, double-blind, placebo-controlled, randomized, parallel-group trial to assess the efficacy and safety of 2 once-daily oral doses of IMU-838…NCT03846219·Blagoevgrad and 37 others

CompletedExamining Effects of Tysabri on Cognitive Fatigue Using fMRIThe purpose of this research study is to investigate the effectiveness of Tysabri on cognitive fatigue in persons with Relapsing-Remitting Multiple Sclerosis (RRMS).NCT04565431·West Orange, New Jersey

PreviousPage 122 of 187Next